Article
Will polygenic risk scores for cancer ever be clinically useful?
21 May 2021
Abstract excerpt
Genome-wide association studies (GWAS) have identified associations between common genetic variants, single nucleotide polymorphisms (SNPs) and the risk of developing different cancers 1 , 2 , 3 . Proponents argue that polygenic risk score (PRS) testing, based on panels of risk SNPs, will revolutionize the prevention and early detection of cancer through individualised risk management strategies and streamlining...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
